166 related articles for article (PubMed ID: 38630705)
1. Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.
Xu L; Bajorski P; Poligone B
PLoS One; 2024; 19(4):e0287444. PubMed ID: 38630705
[TBL] [Abstract][Full Text] [Related]
2. RIPK4 activity in keratinocytes is controlled by the SCF
Tanghe G; Urwyler-Rösselet C; De Groote P; Dejardin E; De Bock PJ; Gevaert K; Vandenabeele P; Declercq W
Cell Mol Life Sci; 2018 Aug; 75(15):2827-2841. PubMed ID: 29435596
[TBL] [Abstract][Full Text] [Related]
3. Receptor-interacting protein kinase 4 and interferon regulatory factor 6 function as a signaling axis to regulate keratinocyte differentiation.
Kwa MQ; Huynh J; Aw J; Zhang L; Nguyen T; Reynolds EC; Sweet MJ; Hamilton JA; Scholz GM
J Biol Chem; 2014 Nov; 289(45):31077-87. PubMed ID: 25246526
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.
Urwyler-Rösselet C; Tanghe G; Leurs K; Gilbert B; De Rycke R; De Bruyne M; Lippens S; Bartunkova S; De Groote P; Niessen C; Haftek M; Vandenabeele P; Declercq W
J Invest Dermatol; 2018 Jun; 138(6):1268-1278. PubMed ID: 29317263
[TBL] [Abstract][Full Text] [Related]
5. A novel regulatory relationship between RIPK4 and ELF3 in keratinocytes.
Scholz GM; Sulaiman NS; Al Baiiaty S; Kwa MQ; Reynolds EC
Cell Signal; 2016 Dec; 28(12):1916-1922. PubMed ID: 27667567
[TBL] [Abstract][Full Text] [Related]
6. RIPK4 activates an IRF6-mediated proinflammatory cytokine response in keratinocytes.
Kwa MQ; Scholz GM; Reynolds EC
Cytokine; 2016 Jul; 83():19-26. PubMed ID: 27014863
[TBL] [Abstract][Full Text] [Related]
7. RIPK4 suppresses the TGF-β1 signaling pathway in HaCaT cells.
Dinçer T; Boz Er AB; Er İ; Toraman B; Yildiz G; Kalay E
Cell Biol Int; 2020 Mar; 44(3):848-860. PubMed ID: 31825120
[TBL] [Abstract][Full Text] [Related]
8. RIPK4 is downregulated in poorly differentiated tongue cancer and is associated with migration/invasion and cisplatin-induced apoptosis.
Wang X; Zhu W; Zhou Y; Xu W; Wang H
Int J Biol Markers; 2014 Jun; 29(2):e150-9. PubMed ID: 24519546
[TBL] [Abstract][Full Text] [Related]
9. Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma.
Xu J; Wu D; Zhang B; Pan C; Guo Y; Wei Q
PeerJ; 2022; 10():e12932. PubMed ID: 35186499
[TBL] [Abstract][Full Text] [Related]
10. [The role of RIPK4 in epidermis physiology].
Wolnicka-Głubisz A; Madej E; Lisek A
Postepy Biochem; 2021 Mar; 67(1):64-71. PubMed ID: 34378900
[TBL] [Abstract][Full Text] [Related]
11. Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients.
Liu DQ; Li FF; Zhang JB; Zhou TJ; Xue WQ; Zheng XH; Chen YB; Liao XY; Zhang L; Zhang SD; Hu YZ; Jia WH
Sci Rep; 2015 Jul; 5():11955. PubMed ID: 26148476
[TBL] [Abstract][Full Text] [Related]
12. A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
De Groote P; Tran HT; Fransen M; Tanghe G; Urwyler C; De Craene B; Leurs K; Gilbert B; Van Imschoot G; De Rycke R; Guérin CJ; Holland P; Berx G; Vandenabeele P; Lippens S; Vleminckx K; Declercq W
Cell Death Differ; 2015 Jun; 22(6):1012-24. PubMed ID: 25430793
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
14. RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells.
Gong Y; Luo X; Yang J; Jiang Q; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1-6. PubMed ID: 30212707
[TBL] [Abstract][Full Text] [Related]
15. RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis.
Fortugno P; Monetta R; Belli M; Botti E; Angelucci F; Palmerini MG; Nottola SA; De Luca C; Ceccarini M; Salvatore M; Bianchi L; Macioce P; Teson M; Ricci F; ; Macchiarelli G; Didona B; Costanzo A; Castiglia D; Brancati F
Hum Mol Genet; 2022 Aug; 31(15):2535-2547. PubMed ID: 35220430
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the Functional Role of RIPK4 in Melanoma.
Madej E; Ryszawy D; Brożyna AA; Czyz M; Czyz J; Wolnicka-Glubisz A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768934
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.
Yan Y; Gauthier MA; Malik A; Fotiadou I; Ostrovski M; Dervovic D; Ghadban L; Tsai R; Gish G; Loganathan SK; Schramek D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765696
[TBL] [Abstract][Full Text] [Related]
19. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.
Heim D; Cornils K; Schulze K; Fehse B; Lohse AW; Brümmendorf TH; Wege H
Oncogene; 2015 Jan; 34(3):364-72. PubMed ID: 24413083
[TBL] [Abstract][Full Text] [Related]
20. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
